1887

Abstract

The spread of antimicrobial resistance among members of the is a significant clinical threat. We report the treatment of pan-resistant bacteraemia with combination tigecycline and colistin in a 49-year-old male and review available therapeutic options. Despite a poor prognosis, the patient recovered, but remains colonized with the pan-resistant isolate.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.023010-0
2010-11-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/59/11/1383.html?itemId=/content/journal/jmm/10.1099/jmm.0.023010-0&mimeType=html&fmt=ahah

References

  1. Agwuh, K. N. & MacGowan, A. ( 2006; ). Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. J Antimicrob Chemother 58, 256––265.[CrossRef]
    [Google Scholar]
  2. CLSI ( 2009; ). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard, 8th edn. M07-A08. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Cunha, B. A. ( 2009; ). Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis. J Clin Microbiol 47, 1613.[CrossRef]
    [Google Scholar]
  4. Elemam, A., Rahimian, J. & Mandell, W. ( 2009; ). Infection with pan-resistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis 49, 271––274.[CrossRef]
    [Google Scholar]
  5. Falagas, M. E., Kastoris, A. C., Kapaskelis, A. M. & Karageorgopoulos, D. E. ( 2010; ). Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10, 43––50.[CrossRef]
    [Google Scholar]
  6. Isenberg, H. D. ( 1992; ). Clinical Microbiology Procedures Handbook. Washington, DC: American Society for Microbiology.
  7. Kelesidis, T., Karageorgopoulos, D. E., Kelesidis, I. & Falagas, M. E. ( 2008; ). Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62, 895––904.[CrossRef]
    [Google Scholar]
  8. Kitchel, B., Rasheed, J. K., Patel, J. B., Srinivasan, A., Navon-Venezia, S., Carmeli, Y., Brolund, A. & Giske, C. G. ( 2009; ). Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53, 3365––3370.[CrossRef]
    [Google Scholar]
  9. Kochar, S., Sheard, T., Sharma, R., Hui, A., Tolentino, E., Allen, G., Landman, D., Bratu, S., Augenbraun, M. & Quale, J. ( 2009; ). Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30, 447––452.[CrossRef]
    [Google Scholar]
  10. Le, J., Castanheira, M., Burgess, D. S., McKee, B., Iqbal, R. & Jones, R. N. ( 2010; ). Clonal dissemination of Klebsiella pneumoniae carbapenemase KPC-3 in Long Beach, California. J Clin Microbiol 48, 623––625.[CrossRef]
    [Google Scholar]
  11. Nordmann, P., Cuzon, G. & Naas, T. ( 2009; ). The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9, 228––236.[CrossRef]
    [Google Scholar]
  12. Palacios, G., Hornig, M., Cisterna, D., Savji, N., Bussetti, A., Kapoor, V., Hui, J., Tokarz, R., Briese, T. & other authors ( 2009; ). Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE 4, e8540.[CrossRef]
    [Google Scholar]
  13. Perez, F., Endimiani, A., Ray, A. J., Decker, B. K., Wallace, C. J., Hujer, K. M., Ecker, D. J., Adams, M. D., Toltzis, P. & other authors ( 2010; ). Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination. J Antimicrob Chemother 65, 1807––1818.[CrossRef]
    [Google Scholar]
  14. Scheetz, M. H., Qi, C., Warren, J. R., Postelnick, M. J., Zembower, T., Obias, A. & Noskin, G. A. ( 2007; ). In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 1621––1626.[CrossRef]
    [Google Scholar]
  15. Vasilev, K., Reshedko, G., Orasan, R., Sanchez, M., Teras, J., Babinchak, T., Dukart, G., Cooper, A., Dartois, N. & other authors ( 2008; ). A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. J Antimicrob Chemother 62, i29––i40.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.023010-0
Loading
/content/journal/jmm/10.1099/jmm.0.023010-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error